Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study

M Rothenberg, J Cox, C Butts, T Hietanen

    Research output: Contribution to journalArticleScientificpeer-review

    166 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1720-1726
    JournalAnnals of Oncology
    Volume19
    Issue number10
    Publication statusPublished - 2008
    Publication typeA1 Journal article-refereed

    Cite this